Journal of Angiology and Lymphology (JAL) is a multidisciplinary journal publishing original research manuscripts, reviews, concisely written clinical and research reports relative to all phases of angiology.
JAL journal is dedicated to advancing effective diagnosis, treatment, prevention and medical and laboratory research, as well as the outcomes of clinical trials in the field of peripheral and cardiovascular diseases. JAL is committed to improve health and quality of life through the practice of vascular medicine and surgery, and supports extensive medical research.
Target first decision within 21 days. Double-blind review by 2-3 field experts.
All articles CC BY 4.0. No paywalls. Compliant with funder mandates worldwide.
Every article receives a unique DOI. Indexed in PubMed, Google Scholar, CrossRef.
Published within 7 days of acceptance. No unnecessary delays in dissemination.
Readers in 170+ countries. Waiver program available for authors from developing nations.
No word limits. Multiple article formats: research, reviews, case reports, short communications.
Submit your original research, reviews, and case reports. No submission fees. Double-blind peer review within 21 days.
Subject areas covered by Journal of Angiology and Lymphology. Click any topic to learn more.
Full aims & scope →Upload your manuscript via our online portal. Quality check within 48 hours.
Double-blind peer review by 2-3 field experts. Target decision: ~21 days.
Constructive feedback from reviewers. Dedicated editorial support throughout.
Published within 7 days. DOI assigned via CrossRef. Globally indexed.
